Philips Opens its First Co-creation Center to Support Care Organizations with the Transformation to New Models for Connected Health Enabled by Digital Technologies

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) has announced the opening of its first HealthSuite Labs co-creation center at High Tech Campus Eindhoven, the Netherlands. The new facility provides an environment to spur digital healthcare innovation and supports healthcare organizations in the transformation towards connected and more value-based, patient-centered care models. Healthcare directors and general practitioners can work together in multidisciplinary teams with patients as well as clinical, design, digital and business experts on the co-creation and implementation of integrated care solutions to enhance self-management and continuity of care for patients.

Following the launch of its facility in the Netherlands, Philips will be rolling out the HealthSuite Lab co-creation centers in other locations globally. Dedicated centers are already planned in Asia and the US to support customers in these regions.

Philips also announced the new collaboration with the regional care network Zorgnetwerk Midden-Brabant (ZMBR), which represents the Elisabeth-TweeSteden Hospital as well as general practitioners, home care nurses, dietitians and patients in the region. Through the HealthSuite Labs co-creation center, the organizations are developing a new regional connected health model for people living with type-2 diabetes - the first such model in the Netherlands.

Under this model, people will be given access to and control over their own actionable health data. They will also be encouraged to set realistic personal goals to support them in making decisions that are important to their health and care management. In this way, the project aims to enhance self-management for patients with diabetes and improve their quality of life. Other important goals are to decrease visits to caregivers, increase treatment and medication loyalty. This collaboration is an example of also how other care providers can co-create in the center to solve the complex challenges that healthcare systems face.

"Most of today's healthcare budget goes to the fast-growing population of people living with chronic illness," said Jeroen Tas, CEO Healthcare Informatics Solutions and Services, Philips. "The pressure on global healthcare systems is increasing, requiring them to find alternative ways of care delivery. At the same time, people want to be more involved in managing their own health.

Together, these factors are shifting healthcare's focus from traditional hospital-based, treat-when-sick (acute) models towards prevention and continuity of care in or near one's home. Our HealthSuite Labs co-creation center will help care providers speed up the development and implementation of new integrated, connected and patient-centric healthcare delivery solutions that enable these new models."

"We want patients to be more empowered to manage their condition and their health," said Veronique Holtmaat, Director Zorgnetwerk Midden-Brabant. "For this we need to improve the collection and exchange of data that various professionals and patients collect and make that data relevant and actionable. By working with Philips in the HealthSuite Labs co-creation center, we gain access to a wealth of know-how plus insight from other stakeholders across the care continuum and can set the next steps in creating truly collaborative and patient-centric care delivery."

Drawing on the effective collection, analysis and sharing of health data, the solutions developed in the HealthSuite Lab co-creation center will be enabled by the HealthSuite Digital Platform, Philips' secure cloud-based IT infrastructure. Philips has collaborated with the Radboudumc REshape Center for their vital contribution to a patient-centric approach in the HealthSuite Labs innovation process.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 106,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

About Zorg Netwerk Midden-Brabant
The regional care network Zorgnetwerk Midden-Brabant is a unique collaboration network of care providers in the central Brabant region in the south of the Netherlands. Together the care providers strive for high-quality, aligned and accessible care and treatment of patients and citizens in the region. The purpose of the diabetes program is to optimize patient care through the development of care-related protocols and collaborative processes. Further, the goal is to innovate the care delivery process together. The regional care network Zorgnetwerk Midden-Brabant focuses on patient self-management and the patient being an active member of society.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...